A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma

Paul G. Richardson, Emily Blood, Constantine S. Mitsiades, Sundar Jagannath, Steven R. Zeldenrust, Melissa Alsina, Robert L. Schlossman, S. Vincent Rajkumar, K. Raman Desikan, Teru Hideshima, Nikhil C. Munshi, Kathleen Kelly-Colson, Deborah Doss, Mary L. McKenney, Svetlana Gorelik, Diane Warren, Andrea Freeman, Rebecca Rich, Anfang Wu, Marta OlesnyckyjKenton Wride, William S. Dalton, Jerome Zeldis, Robert Knight, Edie Weller, Kenneth C. Anderson

Research output: Contribution to journalArticlepeer-review

438 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences